PL3187175T3 - Suplementacyjne preparaty terapeutyczne do sekwencyjnego lub oddzielnego podawania kwasu masłowego i probiotyków - Google Patents

Suplementacyjne preparaty terapeutyczne do sekwencyjnego lub oddzielnego podawania kwasu masłowego i probiotyków

Info

Publication number
PL3187175T3
PL3187175T3 PL16206400T PL16206400T PL3187175T3 PL 3187175 T3 PL3187175 T3 PL 3187175T3 PL 16206400 T PL16206400 T PL 16206400T PL 16206400 T PL16206400 T PL 16206400T PL 3187175 T3 PL3187175 T3 PL 3187175T3
Authority
PL
Poland
Prior art keywords
probiotics
sequential
butyric acid
separate administration
therapeutic formulations
Prior art date
Application number
PL16206400T
Other languages
English (en)
Inventor
Mario Miscioscia
Original Assignee
Euro-Pharma S.R.L.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro-Pharma S.R.L. filed Critical Euro-Pharma S.R.L.
Publication of PL3187175T3 publication Critical patent/PL3187175T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/752—Citrus, e.g. lime, orange or lemon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1664—Compounds of unknown constitution, e.g. material from plants or animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/288—Compounds of unknown constitution, e.g. material from plants or animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PL16206400T 2015-12-22 2016-12-22 Suplementacyjne preparaty terapeutyczne do sekwencyjnego lub oddzielnego podawania kwasu masłowego i probiotyków PL3187175T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITUB2015A009138A ITUB20159138A1 (it) 2015-12-22 2015-12-22 Formulazioni terapeutiche integrative per la somministrazione separata, sequenziale o simultanea di acido butirrico, G.S.E probiotici e prebiotici.
EP16206400.0A EP3187175B1 (en) 2015-12-22 2016-12-22 Supplementary therapeutic formulations for the sequential or separate administration of butyric acid and probiotics

Publications (1)

Publication Number Publication Date
PL3187175T3 true PL3187175T3 (pl) 2021-09-13

Family

ID=55697301

Family Applications (1)

Application Number Title Priority Date Filing Date
PL16206400T PL3187175T3 (pl) 2015-12-22 2016-12-22 Suplementacyjne preparaty terapeutyczne do sekwencyjnego lub oddzielnego podawania kwasu masłowego i probiotyków

Country Status (5)

Country Link
EP (1) EP3187175B1 (pl)
CY (1) CY1124195T1 (pl)
ES (1) ES2875733T3 (pl)
IT (1) ITUB20159138A1 (pl)
PL (1) PL3187175T3 (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL236296B1 (pl) * 2017-08-25 2020-12-28 Przed Produkcji Farmaceutycznej Hasco Lek Spolka Akcyjna Tabletka zawierająca maślan sodu i sposób jej wytwarzania
AT16167U1 (de) * 2017-11-08 2019-03-15 Alcus Med Gmbh Kombinationspräparat zur diätetischen behandlung von darmbeschwerden bei reizdarmsyndrom
IT201800005908A1 (it) * 2018-05-31 2019-12-01 Compressa gastroresistente rivestita con film per il rilascio protratto di acido butirrico
PL425789A1 (pl) * 2018-05-31 2019-12-02 Passio Human Microbiome Spolka Z Ograniczona Odpowiedzialnoscia Kompozycja priebiotyku zawierająca maślan wapnia i maślan magnezu oraz jej zastosowanie
US20190388344A1 (en) * 2018-06-22 2019-12-26 Probiotech Llc Method to Improve The Health Of The Microbiome In A Human Gastrointestinal System and Multi-Chamber Probiotic Delivery Products Therefor
IT201800010473A1 (it) * 2018-11-21 2020-05-21 Neilos S R L Composizione per l’uso nella prevenzione e/o nel trattamento sintomatico della sindrome dell’intestino irritabile.
CN111248443A (zh) * 2020-03-10 2020-06-09 安徽大学 一种具有改善溃疡性结肠炎的合生元组合物及其制剂与应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE525061T1 (de) * 2001-02-28 2011-10-15 Axiomedic Ltd Feste selbst-haftende zusammensetzungen zur topischen behandlung von störungen der mundschleimhaut
ITMI20040187A1 (it) * 2004-02-06 2004-05-06 Cosmo Spa Composizioni farmaceutiche o dietetiche a base di acidi grassi a catena corta e zuccheri complessi per le disfunzioni intestinali
EP2012596A1 (en) * 2006-05-03 2009-01-14 Anidral S.R.L. Symbiotic composition comprising non-digestible polysaccharides and bifidobacteria which metabolize them and its uses
IT1395328B1 (it) * 2009-08-26 2012-09-14 Alpiflor S R L Composizione di acido butirrico miscelato con probiotici e prebiotici
CA2805445C (en) * 2010-07-29 2018-05-01 Cosmo Technologies Ltd. Pharmaceutical and/or dietary compositions based on short chain fatty acids
ITMI20120131A1 (it) 2012-02-01 2013-08-02 Probiotical Spa Batteri probiotici microincapsulati multistrato, loro produzione ed uso
AU2014239883B2 (en) * 2013-03-14 2019-01-17 Therabiome, Llc Targeted gastrointestinal tract delivery of probiotic organisms and/or therapeutic agents

Also Published As

Publication number Publication date
EP3187175B1 (en) 2021-03-31
CY1124195T1 (el) 2022-05-27
ES2875733T3 (es) 2021-11-11
EP3187175A1 (en) 2017-07-05
ITUB20159138A1 (it) 2017-06-22

Similar Documents

Publication Publication Date Title
GB201620066D0 (en) Solid Pharmaceutical dosage formulations and processes
PL3515420T3 (pl) Kompozycje farmaceutyczne do zastosowania w terapii zapalenia brzegów powiek
EP3498297C0 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF AUTISM
IL255109A0 (en) New dihydropyridoisoquinolinones and their pharmaceutical preparations for the treatment of inflammatory disorders
EP4335517B8 (en) Administration and dosage of diaminophenothiazines
EP3268007A4 (en) Compositions and therapeutic methods for the treatment of complement-associated diseases
IL274578A (en) Pharmaceutical compounds and preparations thereof for use in the treatment of leiftic diseases
PT3380525T (pt) Formulações farmacêuticas e métodos que as utilizam
IL266132A (en) Pharmacological formulations and methods for their preparation
HUP1700253A1 (hu) Szilárd orális gyógyszerkészítmények
ZA202006570B (en) Pharmaceutical formulations
IL272495A (en) Pharmaceutical compounds and preparations thereof for use in the treatment of leiftic diseases
EP3291818A4 (en) Compositions and methods for delivering therapeutic agents into the colon
IL261459A (en) Stable formulations for lyophilizing therapeutic particles
IL267279A (en) Pharmaceutical formulations of suvorexant
EP3506947A4 (en) PHARMACEUTICAL FORMULATIONS OF REGADENOSONE
EP3497080A4 (en) PHARMACEUTICAL FORMULATIONS AND THEIR USE
KR20180085033A (ko) 피부 질환 치료용 약학적 제형 및 이의 제조 방법
IL271908A (en) Over-compressed pharmaceutical preparations
ZA201804588B (en) Pharmaceutical formulations for the treatment of diabetes
GB201519644D0 (en) Therapy and pharmaceutical composition
PT3664800T (pt) Formulações terapêuticas que compreendem inibidor da cox-2 e utilizações das mesmas
IL257689B (en) Pharmaceutical preparations and methods for treating diseases related to lack of oxygen
ZA201705329B (en) Pharmaceutical formulations of racecadotril
PL3319586T3 (pl) Formulacja farmaceutyczna do leczenia zmian zapalnych odbytnicy